Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mesodiencephalic dopaminergic (mdDA) neurons originate at the floor plate and floor plate-basal plate boundary of the midbrain ventricular zone. During development mdDA neurons are specified by a unique set of transcription factors and signaling cascades, to form the different molecular subsets of the mdDA neuronal population. In a time series micro-array study performed previously,
mesoderm specific transcript
(
Mest
) was found to be one of the most upregulated genes during early mdDA neuronal development. Here, we show that
Mest
transcript is expressed in the midbrain throughout development and becomes restricted to the substantia nigra (SNc) at late stages. In
Mest
KO animals mdDA neurons are progressively lost in the adult, mostly affecting the SNc, reflected by a 50% decrease of TH protein and DA release in the striatum and a reduction of climbing behavior. Analysis of
Lrp6
KO embryos suggest a subtle opposite phenotype to the
Mest
KO, hinting toward the possibility that specific loss of mdDA neurons in
Mest
ablated animals could be due to affected WNT-signaling. Interestingly, the mdDA neuronal region affected by the loss of
Mest
remains relatively unaffected in
Pitx3
mutants, suggesting that both genes are essential for the development and/or maintenance of different mdDA neuronal subsets within the SNc. Overall, the neuroanatomical and phenotypical consequences detected upon the loss of
Mest
, resemble the loss of SNc neurons and loss of movement control as seen in
Parkinson's Disease
(PD), suggesting that the
Mest
mouse model may be used as a model-system for PD.
...
PMID:
Mest/Peg1
Is Essential for the Development and Maintenance of a SNc Neuronal Subset. 2813 44